0001193125-20-271739 Sample Contracts

AGREEMENT AND PLAN OF MERGER BY AND AMONG ENDO INTERNATIONAL PLC, BETA ACQUISITION CORP. AND BIOSPECIFICS TECHNOLOGIES CORP. DATED AS OF OCTOBER 19, 2020

Merger Agreement • October 19th, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  October 19th, 2020
• Company
  Biospecifics Technologies Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of October 19, 2020 by and among Endo International plc, a public limited company incorporated in Ireland (“Parent”), Beta Acquisition Corp., a Delaware corporation and a wholly-owned Subsidiary of Parent (“Merger Sub”), and BioSpecifics Technologies Corp., a Delaware corporation (the “Company”).

AMENDMENT NO. 1 TO RIGHTS AGREEMENT

Rights Agreement • October 19th, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York

• Contract Type
  Rights Agreement
• Filed
  October 19th, 2020
• Company
  Biospecifics Technologies Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This AMENDMENT NO. 1 TO RIGHTS AGREEMENT, dated as of October 19, 2020 (this “Amendment”), is made and entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), and Worldwide Stock Transfer, LLC, as Rights Agent (the “Rights Agent”). Except as otherwise provided herein, capitalized terms used but not otherwise defined in this Amendment shall have the meanings ascribed to such terms in the Rights Agreement (as defined below).